By contrast, PD-L1/PD-1 is considered to act mainly in the efferent arm (leading from the lymph nodes back to the affected tissue) by modulating the cytotoxic action of CD8+ T cells in the tumor, although PD-1 is also expressed on Tregs, NK, and B cells, while PD-L1 is expressed on myeloid cells in tumors (56, 57). Here, CD274 is linked to neoplasm.